Sequential [(18)F]FDG-[(18)F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience

The aim of this study was to assess whether sequential multiparametric (18)[F]fluoro-desoxy-glucose ((18)[F]FDG)/[(18)F]fluoromisonidazole ([(18)F]FMISO) PET-MRI in breast cancer patients is possible, facilitates information on tumor heterogeneity, and correlates with prognostic indicators. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrzejewski, Piotr, Wengert, Georg, Helbich, Thomas H., Magometschnigg, Heinrich, Georg, Dietmar, Hacker, Marcus, Baltzer, Pascal, Clauser, Paola, Kapetas, Panagiotis, Georg, Petra, Wadsak, Wolfgang, Pinker, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341235/
https://www.ncbi.nlm.nih.gov/pubmed/30728757
http://dx.doi.org/10.1155/2019/1307247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341235/
https://www.ncbi.nlm.nih.gov/pubmed/30728757
http://dx.doi.org/10.1155/2019/1307247

Ejemplares similares